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Background: Spiders have evolved pharmacologically complex venoms that serve to rapidly subdue prey and
deter predators. The major toxic factors in most spider venoms are small, disulfide-rich peptides. While there is
abundant evidence that snake venoms evolved by recruitment of genes encoding normal body proteins followed
by extensive gene duplication accompanied by explosive structural and functional diversification, the evolutionary
trajectory of spider-venom peptides is less clear.
Results: Here we present evidence of a spider-toxin superfamily encoding a high degree of sequence and
functional diversity that has evolved via accelerated duplication and diversification of a single ancestral gene. The
peptides within this toxin superfamily are translated as prepropeptides that are posttranslationally processed to yield
the mature toxin. The N-terminal signal sequence, as well as the protease recognition site at the junction of the
propeptide and mature toxin are conserved, whereas the remainder of the propeptide and mature toxin sequences
are variable. All toxin transcripts within this superfamily exhibit a striking cysteine codon bias. We show that
different pharmacological classes of toxins within this peptide superfamily evolved under different evolutionary
selection pressures.
Conclusions: Overall, this study reinforces the hypothesis that spiders use a combinatorial peptide library strategy
to evolve a complex cocktail of peptide toxins that target neuronal receptors and ion channels in prey and
predators. We show that the ω-hexatoxins that target insect voltage-gated calcium channels evolved under the
influence of positive Darwinian selection in an episodic fashion, whereas the κ-hexatoxins that target insect
calcium-activated potassium channels appear to be under negative selection. A majority of the diversifying sites in
the ω-hexatoxins are concentrated on the molecular surface of the toxins, thereby facilitating neofunctionalisation
leading to new toxin pharmacology.
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Venoms have proven to be key evolutionary innovations
for many divergent animal lineages [1,2]. Although the
most extensively studied venoms are from the medically
important scorpions, snakes, and spiders, venom sys-
tems are present in many other lineages including
cnidarians, echinoderms, molluscs, fish, lizards, and
mammals [1,2]. These venoms have evolved to serve a
variety of purposes, including prey capture, competitor
deterrence, and defense against predators. There has
been considerable innovation both in the chemical
composition of these venoms as well as the method of
venom delivery, which includes barbs, beaks, fangs,
harpoons, nematocysts, pinchers, proboscises, spines,
spurs, and stingers [1,2].
From a molecular evolutionary perspective, the venoms
of snakes are the best understood. There is now abundant
evidence that snake venoms evolved by recruitment of
genes encoding normal body proteins followed by exten-
sive duplication, neofunctionalization, and in some in-
stances relegation to the status of pseudogene [1,3-5]. In
many cases, these genes have been explosively replicated toFigure 1 Distribution, venom collection and venom-gland dissection
Map of the eastern half of Australia showing the distribution of the five spe
funnel-web spider (Hadronyche infensa) from Fraser Island, QLD. In respons
posture, with front legs and pedipalps raised and the fangs in an elevated
tips. (C) A single H. versuta venom gland that has been dissected from the
mygalomorph spiders is located directly below the dorsal surface of the chproduce large multigene families. This process is analogous
to the birth-and-death model of evolution proposed for
multigene families involved in adaptive immunity, such as
the major histocompatibility complex and immunoglobulin
VH genes [6]. However, the evolutionary trajectory is less
clear for the venoms of spiders, scorpions, and molluscs,
which are dominated by disulfide-rich peptides of mass
2–9 kDa [7-12]. These peptides typically possess high affin-
ity and often-exquisite specificity for particular classes of
ion channels and other nervous system targets [13-15].
These neurotoxic functions are perhaps not surprising
given that the primary role of these venoms is to paralyse
or kill envenomated prey [11,16,17].
In this study, we analysed toxin-encoding transcripts
from five species of Australian funnel-web spider (Aranae:
Mygalomorphae: Hexathelidae: Atracinae) from the genera
Atrax and Hadronyche, representing a geographic spread
of more than 2000 km (Figure 1), in order to provide
insight into the evolutionary trajectory of the ω-hexatoxin-
1 (ω-HXTX-1) family. ω-Hexatoxins (formerly known as
ω-atracotoxins) are peptides comprising ~37 residues that
were first isolated from the venom of the lethal Blueof Australian funnel-web spider species used in this study. (A)
cies of Australian funnel-web spider used in this study. (B) Female
e to provocation, the spider has adopted a typical aggressive/defensive
position ready to strike. Note the drop of venom on each of the fang
surrounding muscle tissue. The venom gland in these and other
elicerae.
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The ω-hexatoxins are major components in the venom of
Australian funnel-web spiders [18-20] and they contribute
significantly to prey immobilization by virtue of their ability
to specifically block insect, but not vertebrate, voltage-
gated calcium (CaV) channels [17,18,20-22]. Their po-
tent insecticidal activity has engendered interest in these
peptides as bioinsecticides [11,17,23]. Proteomic analysis
of H. versuta venom revealed a number of ω-HXTX-Hv1a
paralogs [19], suggesting that this peptide toxin might be-
long to a multigene family. However, because the venom
used in this previous study was pooled from several spi-
ders, it was unclear whether these apparent paralogs are
simply polymorphisms resulting from allelic variation.
By using cDNA libraries obtained from a single spider,
we demonstrate here that ω-HXTX-Hv1a is indeed part
of a large multigene family that appears to have arisen
from explosive gene duplication followed by extensive
sequence divergence and neofunctionalization. Within
this superfamily of toxins, we show that pharmacologic-
ally distinct toxin classes are evolving under starkly
different selection pressures, with some toxin classes
accumulating variation under episodic bursts of adapta-
tion, while others remain constrained by negative selec-
tion. This work reinforces the idea that the chemical
and pharmacological diversity present in spider venoms
may have evolved from a relatively small number of an-
cestral genes.Figure 2 Schematic representation of toxin precursors, overall RACE a
(A) Schematic representation of a typical spider peptide precursor showing
mature toxin in black. After translation, the signal and propeptide regions a
General overview of the RACE protocol for sequencing hexatoxin transcript
library preparation. In both 3’ and 5’ RACE, gene-specific primers are used i
full-length sequences. The resulting PCR products are then cloned and seq
highlighting the combinatorial nature of spider-venom peptides.Results and discussion
The ω-hexatoxins are expressed as prepropeptide
precursors
RACE analysis was used to amplify transcripts encoding
orthologs of ω-HXTX-Hv1a from four species of Australian
funnel-web spider: Atrax robustus, H. infensa, H. venenata,
and H. versuta (Figure 2). Multiple ω-HXTX-Hv1a ortho-
logs were identified in each species (i.e., 24 paralogs encod-
ing seven distinct mature toxins were identified in H.
infensa, 18 paralogs encoding six mature toxins were identi-
fied in the Sydney funnel-web spider A. robustus, and eight
paralogs encoding two mature toxins identified in the
Tasmanian funnel-web spider H. venenata) (Figure 3A).
A further eight paralogs encoding four distinct mature
toxins were identified in the venom-gland transcriptome
of H. modesta (Figure 3A). Thus, the amino acid sequence
diversity previously reported for ω-HXTX-1 based on ana-
lysis of pooled venom samples [19] is due to expression of
multiple related transcripts in a single spider rather than
allelic variation. The almost complete conservation of the
signal sequence, as well as the pattern of conserved cyste-
ines in the mature toxin (Figure 3A), indicates that these
ω-HXTX-Hv1a homologs arose by duplication and se-
quence divergence of the original toxin-encoding gene.
All of the ω-HXTXs are expressed as prepropeptide
precursors that are posttranslationally processed to yield
the mature toxin sequence (Figure 2A). The highly hydro-
phobic 22-residue signal sequence is of similar length tomplification strategy and identification of toxin superfamilies.
the signal peptide in orange, the propeptide in purple, and the
re proteolytically removed to yield a functional mature toxin. (B)
s. Adaptors are added to the 5’ and 3’ end of transcripts during cDNA
n the forward (3’ RACE) or reverse (5’ RACE) orientation to amplify
uenced. (C) Schematic representation of the Shiva superfamily
Figure 3 Sequence alignments of ω and κ -hexatoxins. (A) Sequence alignment of ω-HXTX-Hv1a paralogs from each species: Hadronyche
modesta (Hmo1a–Hmo1d), Atrax robustus (Ar1a–Ar1g), Hadronyche infensa (Hi1a–Hi1g), and Hadronyche venenata (Hvn1a and Hvn1b). The level of
residue conservation is graded from black (fully conserved across all paralogs) to dark grey (conserved in most toxins) to light grey (conserved in
a majority of orthologs). The lines below the sequence alignment indicate the disulfide-bond connectivity of ω-HXTX-Hv1a. (B) Alignment of
κ-HXTX-Hv1a paralogs from Hadronyche versuta and one ortholog from Hadronyche modesta. The level of residue conservation is graded as in
panel (A) and the signal peptide, propeptide, and mature toxin regions are highlighted. The lines below the sequence alignment indicate
the disulfide-bond connectivity of κ-HXTX-Hv1c, with the vicinal disulfide bond highlighted in red. Note that ω-HXTX-Ar1a (UniProt PF06357),
ω-HXTX-Hi1a (UniProt P0C2L5), ω-HXTX-Hi1b (UniProt P0C2L6), ω-HXTX-Hi1c (UniProt P0C2L7), and κ-HXTX-Hv1c (UniProt P82228) have been
previously isolated directly from venom.
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scorpions, and cone snails [8]. The 20-residue propeptide
sequence is highly acidic, with a net charge of −4, a feature
that has been noted for numerous spider-toxin propeptide
sequences [24-28] but which is not characteristic of toxin
precursors from other venomous animals. Moreover,
the presence of a propeptide region contrasts with most
scorpion-toxin precursors in which the signal sequence
is fused directly to the mature toxin without an inter-
vening propeptide [8]. The reason for the highly acidic
propeptide region in spider toxin precursors remains to
be determined, but it may be related to specific interac-
tions between the toxin precursor and components of
the secretory and/or protein folding pathway in spider
venom glands.
The propeptide sequence terminates with a dibasic Arg-
Arg signature; dibasic sequences are common recognition
sites for proteolytic removal of propeptide segments in
neuropeptide precursors from both vertebrates [29] and
invertebrates [30]. While Arg is the terminal residue in
virtually all known spider-toxin propeptide sequences, the
penultimate residue is variable, though it is commonly
Asp, Glu, or Lys [25,26,31-33].
ω-hexatoxins belong to a large toxin-gene superfamily
Orthologs of ω-HXTX-Hv1a were identified in all five
species of Australian funnel-web spider examined in thisstudy. These species are distributed along the eastern
seaboard of Australia with a geographic spread of more
than 2000 km (Figure 1). The hexathelids are a group of
approximately 40 species divided into three genera: Atrax,
Hadronyche and Illawarra [34-36]. They are adapted to
forest environments but can also be found in habitats that
range from montane herblands and open woodland to
closed forest [36]. Conservation of the ω-hexatoxin family
of toxins over this wide range of environments and differ-
ing prey distributions implies that there has been strong
evolutionary pressure to maintain these peptides as part of
the venom arsenal, which is perhaps not surprising given
that they are broadly active against many different arthro-
pods [11,17,37].
In addition to obvious homologs of ω-HXTX-Hv1a,
the RACE and transcriptomic analyses revealed add-
itional families of toxins that had almost identical signal
sequences to the ω-HXTX-1 transcripts, but divergent
propeptide and mature toxin sequences. We named one
of these families the ω/κ-HXTX family (described as U-
ACTX in [38]). The ω/κ-HXTX peptides appear to be dis-
tributed in two of the species examined (A. robustus and
H. versuta); this reinforces the idea that these toxins most
likely arose ancestrally by duplication of a ω-HXTX-1
gene followed by hypermutation of the propeptide and
mature-toxin regions in order to create a new function
(neofunctionalization). The conservation and radiation of
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are not nonfunctional relics of an explosive radiation of
this toxin-gene superfamily, and we confirmed this by
showing that recombinant ω/κ-HXTX-Hv1a is highly
insecticidal [38]. The high insecticidal potency of this
family of peptides is believed to result from a synergistic
effect on insect voltage-gated calcium (CaV) channels
and calcium-activated potassium (KCa) channels [38].
RACE analysis of the venom-gland cDNA library from
H. versuta also led to amplification of transcripts encoding
the insecticidal toxin κ-HXTX-Hv1c [39], and sequencing
of the venom-gland transcriptome from H. modesta also
uncovered an ortholog of this toxin (Figure 3B). This was
entirely unexpected since this toxin has a vastly differ-
ent primary structure to ω-HXTX-Hv1a [39]. Moreover,
in addition to the six conserved cysteine residues in ω-
HXTX-Hv1a that form an inhibitor cystine knot (ICK)
motif [40,41], κ-HXTX-Hv1c contains two additional
cysteine residues that form an extremely rare vicinal disul-
fide bond [42-44]. Furthermore, in contrast to ω-HXTX-
Hv1a, which blocks insect CaV channels, κ-HXTX-Hv1c is
a potent and specific blocker of KCa channels [45]. Never-
theless, the near identity of the signal sequence in these
two toxin families and the conservation of cysteine resi-
dues in the mature toxin indicate that they evolved from
the same ancestral toxin gene and are members of the
same gene superfamily.
We did not find orthologs of κ-HXTX-Hv1c in any of
the other three species of Australian funnel-web spider (H.
infensa, A. robustus, and H. venenata). However, κ-HXTX-
Hv1a, κ-HXTX-Hv1b, and κ-HXTX-Hv1c are expressed at
very low levels in H. versuta venom [42], and conse-
quently we cannot rule out the possibility that these
toxins are present in the venom of the other three spi-
ders but the transcript levels are too low to be detected
using the methods employed here.
The Shiva superfamily of peptide toxins
It has previously been suggested that superfamilies of
spider-venom peptides evolved from a single ancestral
gene via explosive gene duplication [8]; the work de-
scribed here further supports this idea as it is clear that
the ω-HXTXs, ω/κ-HXTXs, and κ-HXTXs belong to a
large superfamily of toxins that arose via gene duplica-
tion (Figure 2C). We have chosen to name spider-toxin
gene superfamilies after deities of death and destruction
since the major biological role of these toxins is to
paralyze and/or kill envenomated prey. Accordingly, we
have named the ω/κ-HXTX/ω-HXTX/κ-HXTX gene
superfamily after the Hindu deity Shiva, commonly
known as the “destroyer”.
Sequence logos were previously used to analyse differ-
ences in the level of sequence conservation between the
three parts of the ω-HXTX toxin precursor, namely thesignal peptide, propeptide, and mature toxin [8]. A re-
vised logo analysis of the Shiva superfamily (Figure 4A)
that incorporated all of the new sequences and species
reported here reinforced the dichotomy in evolutionary
forces affecting various elements of the toxin precursor.
The signal peptide has clearly been highly conserved
throughout the evolution of this toxin superfamily and it is
presumably under negative selection in order to ensure
that these toxins are directed to the appropriate secretory
pathway. In contrast, there is significant sequence variation
in both the propeptide and mature toxin sequences, with
two notable exceptions. First, in contrast to the highly
variable upstream region of the propeptide sequence, the
C-terminal proteolytic recognition signal (Arg-Arg) is
completely preserved (Figure 4A). Presumably there has
been strong selection pressure to ensure processing of the
propeptide by a specific protease. Second, in contrast to
the overall low level of conservation of the mature toxin
sequence, the cysteine residues, which direct the three-
dimensional (3D) fold of the toxins, are completely con-
served (Figure 4A). The marked variation in levels of
sequence conservation between the spider-toxin signal
sequence and the propeptide and mature toxin regions
is reminiscent of that observed for superfamilies of cone
snail toxins [46-51].
There are two striking differences between the Shiva
superfamily precursors and transcripts encoding human
neuropeptides and other secreted proteins. First, whereas
precursors of human neuropeptides often encode multiple
mature neuropeptide sequences [29,52], we and others
have not found any examples of spider-toxin transcripts
that encode more than a single mature toxin sequence.
Secondly, in direct contrast to the toxin precursors, the
sequence of the mature human neuropeptide(s) is usually
strongly conserved whereas there is significantly more
variability in the signal sequence. This is perhaps not sur-
prising given that human neuropeptides usually act on a
single well-defined molecular target whereas spider toxins
typically target a specific subtype of receptor or ion chan-
nel that nevertheless might vary significantly in primary
structure between prey taxa (Note that most spiders are
generalist predators that target a phylogenetically diverse
range of prey). Thus, expressing a family of related toxins
in the venom (essentially a mini-combinatorial peptide li-
brary) might ensure that the desired receptor/ion channel
is targeted, regardless of prey taxa.
Position-specific cysteine codon bias
Mature ω-HXTXs contain three disulfide bonds with 1–
4, 2–5, 3–6 connectivity. These disulfides form an ICK
motif that provides these toxins with a high degree of
chemical, thermal and biological stability [53]. Although
it is clear from a protein structure viewpoint why these
six cysteine residues need to be strictly maintained in
Figure 4 Sequence logo and codon usage analysis from the Shiva superfamily. (A) Sequence logo [54] based on alignment of
prepropeptides from the Shiva superfamily. There is a much higher level of sequence conservation within the signal peptide than within the
propeptide and mature toxin regions. Note, however, that the cysteine residues that form the cystine-knot motif in the mature toxin and the
Arg-Arg protease recognition site that terminates the propeptide region are both completely conserved (highlighted in blue and red,
respectively). (B) Codon usage for the six-cysteine residues that form the cystine-knot motif. Note the strong bias for TGC at cysteine positions 1,
3, 4, and 6. Shown above the histogram is the disulfide bridge arrangement for the six cysteines as inferred from the 3D structures of
ω-HXTX-Hv1a and κ-HXTX-Hv1c.
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expect to find a preference for either one of the two pos-
sible cysteine codons (TGT and TGC). Intriguingly,
however, previous analysis of ω-HXTX precursors re-
vealed a strong bias for TGC at four of the six cysteine
positions in the mature toxin region [8]. An extended
logo analysis [54] incorporating all of the newly discovered
sequences reported in this study corroborated the previ-
ously observed codon bias (Figure 4B). We found an ex-
treme TGC codon bias for the four cysteine residues that
form the 1–4 and 3–6 disulfide bridges in the ω-HXTX
family but not for the two cysteines that form the 2–5disulfide bond (Figure 4B). The observed position-specific
codon bias is not simply a manifestation of global codon
bias in these spiders as we have observed a preference for
TGT as opposed to TGC for cysteine residues in other
hexatoxin superfamilies (data not shown). Moreover, we
did not observe extreme codon bias for any other con-
served residue in the mature hexatoxins.
Position-specific cysteine-codon bias has also been ob-
served in superfamilies of cone snail toxins and it has
been proposed that these codons might serve as attrac-
tants for a mutator complex that includes a poorly pro-
cessive and highly mutagenic polymerase (e.g., DNA Pol
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facilitating hypermutation of the mature toxin region
[49,50]. However, there is currently no direct evidence
that cysteine-codon bias plays a part in directing the
evolution of spider or cone snail toxins.
Molecular evolution analyses
We utilized various state-of-art molecular evolutionary
assessment methods to determine the influence of nat-
ural selection on the evolution of genes encoding Shiva
superfamily toxins (see Methods section for full details
of the selection analyses). The one-ratio model, the sim-
plest of the codon-specific models, estimated the non-
synonymous-to-synonymous nucleotide-substitution rate
ratio (ω) to be 0.64, 1.06 and 0.69 for the ω-HXTXs,
κ-HXTXs, and combined Shiva superfamily dataset, re-
spectively (Additional file 1: Table S1–3). This highly
conservative model can only detect positive selection
when ω, averaged over all sites along the lineages in a
phylogenetic tree, is significantly greater than one. As
lineage-specific models of PAML, such as the one-ratio
model, often fail to detect positive-Darwinian selection
that only affects certain sites in proteins, we also employedTable 1 Nucleotide and complementary protein analyses for ω
Sitea CodeML
Codon Amino Acid M2ab M8c
21 E 0.99 ± 0.38 0.87 ± 0.42
(0.201) (0.257)
40 V 1.41 ± 0.49 1.47 ± 0.37
(0.589) (0.842)
44 S 1.25 ± 0.37 1.28 ± 0.41
(0.420) (0.647)
53 H 1.62 ± 0.63 1.55 ± 0.36
(0.749) (0.929)
57 G 1.39 ± 0.48 1.45 ± 0.38
(0.570) (0.825)
60 T 0.80 ± 0.44 0.71 ± 0.41
(0.122) (0.154)
64 N 0.53 ± 0.40 0.51 ± 0.30
(0.031) (0.036)
69 T 1.34 ± 0.45 1.38 ± 0.40
(0.507) (0.751)
72 R 1.10 ± 0.33 1.01 ± 0.42
(0.26) (0.374)
aSites detected as positively selected using the integrative approach.
bM2a Bayes empirical Bayes (BEB) posterior probability and post-mean ω indicated
cM8 Bayes empirical Bayes (BEB) posterior probability and post-mean ω indicated in
dAmino acid property under selection (MW: molecular weight; MV: molecular volume
eMagnitude if selection on the amino acid property.
fAccessible surface area of 10–20% corresponds to buried residues, 40–50% indicate
exposed residues.site-specific models (Table 1: codon numbers based on κ-
HXTX-Hv1c_2 and ω-HXTX-Ar1a_1; Additional file 1:
Table S1–3). Model 8 estimated ω of 0.69, 1.06 and 0.78
for the ω-HXTXs, κ-HXTXs, and the combined Shiva
superfamily dataset, respectively (Table 2 and Additional
file 1: Table S1–3). Although the computed ω for the
κ-HXTXs was >1, the assessment was not statistically
significant (p > 0.05) in comparison with the null model
(M7 β). The Bayes Empirical Bayes (BEB) approach imple-
mented in M8 was only able to identify one positively se-
lected site in the combined toxin dataset (Table 2 and
Additional file 1: Table S3). Thus, the site-specific models
failed to detect the influence of adaptive selection pres-
sures in shaping evolution of the Shiva superfamily. In
contrast, the more advanced Fast, Unconstrained Bayesian
AppRoximation (FUBAR) [55,56] implemented in HyPhy
detected a handful of positively selected sites in both the
ω-HXTXs and the combined dataset (Table 1).
Site-specific models for detecting positive selection
work best when detecting pervasive selection pressures.
However, the majority of positively selected sites are
often subjected to transient or episodic adaptations. When
the majority of lineages evolve under the influence oftoxins
Tree SAAP Accessible
surface areafPropertyd Magnitudee
- - -
MW, MV, V
0, μ 8, 8, 8, 8 42.0
Partially exposed
MW, MV, V
0, μ 8, 8, 8, 8 82.1
Exposed
- - 0.0
Buried
- - 57.3
Exposed
- - 49.7
Exposed
- - 100.0
Exposed
- - 59.8
Exposed
- - 0.0
Buried
in parentheses.
parentheses.
; V0: partial specific volume; μ: Refractive index).
s partially exposed amino acid residues, and ≥50% indicates solvent
Table 2 Molecular evolution of ω and κ toxins from
Australian funnel-web spiders
FUBARa MEMEb PAMLc
M8 M2a
ω ω >1d: 3 7 0 0
toxins ω <1e: 5 0 0
0.69 0.73
κ ω >1a: 1 0 0 0
toxins ω <1b: 0 0 0
1.06NS 1.06NS
ALL ω >1a: 3 8 1 0
toxins ω <1b: 7 (0 + 1) 0
0.78 0.83
aFast, Unconstrained BayesianApproximation (FUBAR).
bSites detected as experiencing episodic diversifying selection (0.05
significance) by mixed effects model evolution (MEME).
cPositively selected sites detected using the Bayes empirical approach
implemented in the site models M8 and M2a. Number of positively selected
sites detected at the posterior probability ≥0.99 and 0.95 are indicated in
parenthesis. ω computed using M8 and M2a are also presented.
dNumber of sites evolving under the influence of pervasive diversifying
selection, detected by FUBAR at 0.9 posterior probability.
e Number of sites evolving under the influence of pervasive purifying
selection, detected by FUBAR at 0.9 posterior probability.
ω =mean dN/dS.
NS = not significant at 0.05 compared to the null model (M7: beta).
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tion that influences only a small number of lineages. In
such scenarios, the aforementioned analyses may fail to
detect the influence of positive selection. To address the
shortcomings of the aforementioned approaches, we
employed the advanced Mixed Effects Model Evolution
(MEME) [57], which uses fixed effects likelihood (FEL)
along the sites and random effects likelihood (REL)
across the branches to detect episodic diversifying selec-
tion. MEME is capable of identifying both pervasive and
episodic adaptations. MEME identified 7 and 8 episodic-
ally diversifying sites in the ω-HXTXs and combined
toxin dataset, respectively (Table 2), highlighting the
vital role of episodic diversifying selection in shaping
the evolution of these spider toxins. Six out of eight epi-
sodically diversifying sites (75%) were located on the
molecular surface of the toxins (Table 1 and Figure 5B)
with their side chains completely or partially exposed to
solvent, suggesting that they could act as pharmaco-
logical sites and participate in prey envenomation; these
findings are also in agreement with the selection forces
found on the surface of the SGTx toxin family from the
venom of the African Baboon spider Scodra grisiepies
[58]. Rapid Accumulation of Variations in Exposed Resi-
dues (RAVER), where the toxin molecular chemistry
undergoes hypervariations under the influence of posi-
tive Darwinian selection and focal mutagenesis [59], has
been documented in a plethora of venom-components
from a wide diversity of venomous animal lineages[59-64]. Since the synthesis and secretion of venom pro-
teins is energetically expensive [65-67], mutations that
disrupt the structure/function of proteins are filtered
out of the population by negative selection over time, fa-
voring the conservation of catalytic and structurally im-
portant residues. RAVER not only aids in generation of
a rapidly variable toxin molecular surface biochemistry,
but it also ensures the conservation of structurally and
functionally important residues. Accumulation of varia-
tions on the molecular surface of the toxin is advanta-
geous as the altered surface chemistry might lead to
new toxin functions (neofunctionalisation).
To derive further support for the positively selected sites
detected by nucleotide analyses, we employed a comple-
mentary protein-level approach implemented in TreeSAAP
(Table 1). TreeSAAP identified two positively selected sites
in the ω-HXTXs that were in common with the sites iden-
tified by site-model 8 of PAML (Table 1). Evolutionary
fingerprint analyses (Figure 5A) clearly revealed several res-
idues in the ω-HXTXs and the combined toxin dataset that
evolve under the influence of positive selection, while a
majority of residues in the κ-HXTXs remained under evo-
lutionary constraint (Figure 5A,B). Thus, evolution of the
ω-HXTXs has been significantly influenced by short bursts
of episodic adaptations, while the κ-HXTXs appear to be
under negative selection.
Phylogenetic analysis revealed that the κ-HXTXs form
a separate clade to the ω-HXTXs, rendering the Shiva
superfamily non-monophyletic (Figure 6). There are
also significant variations within the ω-HXTXs suggest-
ive of functional diversification (Figure 6). The “hybrid”
ω/κ-HXTXs exhibit functional characteristics of both
the ω-HXTXs and κ-HXTXs as they block CaV channels
(like the ω-HXTXs) as well as KCa channels (like the κ-
HXTXs). The functional activity of the ω/κ-HXTXs
combined with their relative phylogenetic placement and
cysteine pattern indicates that they are structurally and
functionally intermediate between the ω- and κ-HXTXs.
The evolution of new cysteine residues to create the vici-
nal disulfide bond in the κ-HXTXs potentiated toxin
activity on KCa channels, since mutagenesis and analogue
studies indicate that this vicinal disulfide bond is the most
critical part of the KCa pharmacophore [43,45,68].
Constraints on mutation of the mature toxin sequence
It is generally considered that conservation of the cyst-
eine scaffold in toxin-gene superfamilies is critical for
conserving the toxin’s 3D fold [35]. However, the incred-
ible disparity in the amino acid sequence between ω-
HXTX-Hv1a and κ-HXTX-Hv1c (Figure 7A) begs the
question of whether this is reflected in a significant differ-
ence in their 3D structures, despite their common cystine-
knot scaffold. The 3D structure of both toxins has
been determined previously using homonuclear NMR
Figure 5 Molecular evolution analyses of κ- and ω-HXTXs. (A) Evolutionary fingerprint of κ- and ω-HXTXs. Estimates of the distribution of
synonymous (α) and non-synonymous (β) substitution rates inferred for the κ-HXTXs, ω-HXTXs, and the combined Shiva superfamily dataset. The
ellipses reflect a Gaussian-approximated variance in each individual rate estimate, and colored pixels show the density of the posterior sample of
the distribution for a given rate. The diagonal line represents the idealized neutral evolution regime (ω = 1), while points above and below the
line correspond to positive selection (ω > 1) and negative selection (ω < 1), respectively. The ω for site model 8, along with the total number of
positively selected sites detected by its Bayes Empirical Bayes (BEB) approach and the number of episodically diversifying sites detected by the
mixed effects model of evolution (MEME), are also indicated. (B) Molecular evolution of Shiva superfamily toxins from Australian funnel-web
spiders. 3D homology models are shown with their molecular surface colored according to the evolutionary conservation of amino acids (see
color key); the location of positively selected sites is shown in red in space-fill models and as red spheres in wireframe models. A line plot is also
provided to highlight the relative accumulation of dN versus dS, estimated using the M0 model of PAML. NS: Not significant.
Pineda et al. BMC Genomics 2014, 15:177 Page 9 of 16
http://www.biomedcentral.com/1471-2164/15/177spectroscopy [18,42] and their pharmacophores elucidated
using alanine scanning mutagenesis [17,21,43,69].
Figure 7B and C show schematic representations of
the 3D structure of κ-HXTX-Hv1c and ω-HXTX-Hv1a,
respectively. The two toxins can be considered to com-
prise four inter-cystine loops, which are labelled 1–4 from
N- to C-terminus. Although there is an obvious similarity
in the disposition of the three centrally located disulfide
bridges that form the cystine-knot motif in each toxin, the
overall topology of the toxins, as well as the size and
relative orientation of the four inter-cystine loops, ap-
pears quite different. However, the structural overlay in
Figure 7D, which was generated automatically by the
DaliLite structural alignment program [70], reveals that
the two structures are in fact remarkably similar.
The DaliLite alignment yields a root mean square
deviation of 2.4 Å over the backbone atoms of the 28
aligned residues, indicating that the two toxins are in-
deed structural homologs. The three central disulfide
bridges and loop 1 align remarkably well. Loop 4, which
encompasses the β-hairpin present in both toxins, also
aligns well except for the four-residue insertion in
ω-HXTX-Hv1a (Figure 7A), which increases the size of
the hairpin loop at the tip of Loop 4. The majorstructural differences between the two toxins are the
very different orientations of loops 2 and 3. However,
these structural variations cannot disguise the fact that
the two toxins essentially conform to the same 3D scaf-
fold despite their extraordinary sequence divergence
(16% identity if the cysteine framework is excluded).
This ability to maintain a consistent molecular architec-
ture despite massive variation in the inter-cystine loop
sequences has important implications for the mechanism
by which this superfamily of peptide toxins has evolved.
Conclusions
Spiders and other venomous animals rely on the produc-
tion of pharmacologically complex venoms for defense,
prey capture, and competitor deterrence. The major com-
ponents of most spider venoms are disulfide-rich peptides
that have evolved to target a wide range of receptors and
ion channels in the insect nervous system. The ω-HXTX
and κ-HXTX families were the first peptides isolated from
Australian funnel-web spiders that were shown to be in-
secticidal [17]. Analysis of all transcripts encoding these
peptides showed that they are initially expressed as pre-
propeptides that are proteolytically processed to yield a
36–37 residue mature peptide that contains three disulfide
Figure 6 Bayesian phylogenetic tree representing the molecular evolutionary history of the Shiva superfamily toxins. The tree shows
the split between the three main toxin classes (ω, κ, and ω/κ). ω-Actinopoditoxin-Mb1a from the Eastern mouse spider Missulena bradleyi was
used as the outgroup. Toxins belonging to each species are highlighted in the following colours: H. versuta, red; H. modesta, black; H. venenata,
green; H. infensa, magenta; A. robustus, pale blue; H. formidabilis, dark blue; ω-actinopoditoxin-Mb1a from M. bradleyi, orange. *denotes a species
not sequenced as part of this study; the sequence was downloaded from UniProt under accession number P83588.
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nal disulfide bond in the κ-HXTXs.
The extreme diversity of primary structure within the
Shiva toxin superfamily suggests that there have been
few evolutionary restraints on sequence diversification
outside of the disulfide bridges that direct the 3D fold of
these peptides. The ω-HXTXs, in particular, seem to
have evolved under the influence of positive Darwinian
selection in an episodic fashion, whereas the κ-HXTXs
appear to be constrained by negative selection pressures.
Functional assessments of these toxins should shed fur-
ther light on why they have adopted quite contrasting
molecular evolutionary regimes. ω-HXTXs were also
found to have adopted RAVER, where a large number of
the episodically diversifying sites are concentrated on
the molecular surface, facilitating the generation of novelpharmacological sites. These toxins may therefore be good
candidates for in vitro evolution studies designed to pro-
duce modified peptides with desired therapeutic [14] or
agrochemical [11] properties. Most importantly, this study
reinforces the idea that the remarkable chemical and
pharmacological complexity of spider venoms may be de-
rived from a relatively small number of ancestral genes.
Methods
Identification of ω-HXTX-1 homologs via rapid
amplification of cDNA ends
Venom-gland cDNA libraries were prepared from indi-
vidual specimens of the following species of Australian
funnel-web spider (Arthropoda: Chelicerata: Arachnida:
Araneae: Opisthothelae: Mygalomorphae: Hexathelidae):
Hadronyche infensa, H. versuta, H. venenata, and Atrax
Figure 7 Structural comparisons of κ-HXTX-Hv1c and ω-HXTX-Hv1a. (A) Comparison of the primary structures of κ-HXTX-Hv1c and ω-HXTX-
Hv1a. Identities are boxed and shaded orange while the conserved cysteines that form the cystine-knot motif in each toxin are coloured red.
(B) Richardson representation of the 3D structure of κ-HXTX-Hv1c (PDB accession code 1DL0; [42]) and (C) ω-HXTX-Hv1a (PDB accession code
1AXH; [18]). Disulfide bonds are shown as orange tubes. The inter-cystine loops and the N- and C-termini are labelled. (D) Stereo-view of an
overlay of the 3D structures of κ-HXTX-Hv1c (dark blue with light-blue disulfide bonds) and ω-HXTX-Hv1a (raspberry with light-salmon disulfide
bonds). The structural alignment, which was automatically generated by DaliLite [70], yielded a root mean square deviation of 2.4 Å over the
backbone atoms of the 28 aligned residues (Ala1–Ala11, Pro15–Pro18, Ser21–Asn27, and Gly28–Arg33 in κ-HXTX-Hv1c versus Pro2–Pro12, Asn16–
Ser19, Ser21–Asn27, and Thr32–Asp37). The inter-cystine loops and the N-terminus are labelled. Figures generated using MacPyMOL [91].
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tinct regions of Australia (Figure 1A). Spiders were cooled
to −20°C for 40–60 min, then paired venom glands were
carefully dissected from each specimen (Figure 1C). Each
pair of venom glands was combined, then polyA +mRNA
was extracted using a QuickPrep Micro mRNA Purifica-
tion Kit (Amersham Pharmacia Biotech/GE HealthcareLife Sciences, Rydalmere, NSW, Australia) and stored at
−20°C until further use. cDNA libraries were constructed
using a Marathon cDNA Amplification Kit (Clontech
Laboratories, Mount View, CA, USA). From the mRNA
template, single-stranded cDNA was constructed using
Superscript III reverse transcriptase (Life Technologies,
Grand Island, NY, USA) and a poly(dT) anchor primer
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sis was performed according to the kit specifications ex-
cept the cDNA was purified using a Concert Rapid PCR
Purification kit (Gibco/Life Technologies) instead of a
phenol/chloroform extraction. A Marathon cDNA Ampli-
fication adaptor (Clontech Laboratories) was then ligated
to the double-stranded cDNA. After overnight ligation,
the sample was precipitated using 10 μl of 5% w/w glyco-
gen, 10 μl of 3 M sodium acetate pH 5.2, and 100 μl of
100% ethanol at −20°C. The sample was subsequently
washed with 80% ethanol and dried for 10 min prior to re-
suspension in Tris-EDTA buffer.
Transcripts encoding ω-HXTX-Hv1a and paralogs/
orthologs thereof were subsequently obtained via rapid
amplification of cDNA ends (RACE) (Figure 2B) [71]. A
redundant 3’ PCR primer based on residues 24–31 of
ω-HXTX-Hv1a (ω-HV1 5’ RTTNCCRTTYTCRTTYT
CYTTRAA 3’) was used in conjunction with a 5’ univer-
sal adaptor primer in a 5’ RACE experiment designed to
extract information about the upstream region of the
ω-HXTX-Hv1a transcript (EchoAP1: 5’ CACCCCTAA
TACGACTCACTATAGG 3’). A gene-specific primer for
3’ RACE was then designed based on the leader se-
quence obtained from the 5’ RACE experiment (3’ RACE
primer: 5’ TGCTGCAATATGAATACCGC 3’. This pri-
mer was used in combination with the Echoclonanch-2
oligo(dT) primer (5’ GGGCAGGTTTTTTTTTTTTTT
TTT 3’) to generate transcripts that encode a signal se-
quence homologous to that of ω-HXTX-Hv1a.
PCR products were extracted from agarose gels using
a Gibco gel purification kit, precipitated using Pellet Paint
Co-Precipitant kit (Novagen/EMD Millipore, Billerica,
MA, USA), then phosphorylated with kinase in prepar-
ation for cloning. PCR products were then ligated into
pSMART and transformed into E. cloni cells (Lucigen,
Middleton, WI, USA) using the Lucigen CloneSmart Blunt
Cloning kit. Transformed clones were cultured for one
hour in Recovery Medium, then plated with 50 μg/mL
ampicillin to allow for overnight growth. PCR screening
was then used to select colonies with the expected insert
size for DNA sequencing. DNA sequences (and the cor-
responding protein sequences) were collated and ana-
lysed using Geneious Pro, version 3.8.5 [72] and signal
sequence cleavage sites were predicted using SignalP,
version 3.0 [73].
Identification of ω-HXTX-1 homologs via transcriptomics
Paired venom glands from Hadronyche modesta were
dissected out and pooled. Total RNA was extracted
using the standard TRIzol® Plus method (Invitrogen/Life
Technologies) according to the manufacturer’s protocol.
One microgram of Total RNA was used to construct a
cDNA library using the CREATOR™ SMART™ cDNA li-
brary construction kit (Clontech Laboratories) followingthe manufacturer’s protocol. Briefly, total RNA was re-
versed transcribed using the SMART™ Moloney Murine
Leukemia virus (MMLV) reverse transcriptase. Second-
strand synthesis was completed using long distance poly-
merase chain reaction (PCR) as follows: 1 min at 95°C
followed by 20 cycles of 1 min at 95°C and 6 min at 68°C.
Products were then digested and size fractionated using a
CHROMA SPIN-400 DEPC-H2O column (Clontech La-
boratories) and then ligated into the pDNR-lib donor
vector. Recombinant plasmids were electroporated into E-
shot™ DHB10™-T1R electro competent cells (Invitrogen/
Life Technologies). 384 clones were randomly selected and
sequenced by capillary electrophoresis on an Applied Bio-
systems 3730×l DNA analyzer (Applied Biosystems/Life
Technologies) at the Brisbane node of the Australian Gen-
ome Research Facility (AGRF). Sequences were processed
so vector and polyA + tails were clipped using CLC Main
Work Bench (CLC-Bio), and the Blast2GO bioinformatic
suite [74,75] was used to provide Gene Ontology, BLAST
and domain/Interpro annotation. Signal sequence cleavage
sites were predicted using SignalP, version 3.0 [73].
Nomenclature
In accordance with the recently introduced systematic
nomenclature for naming peptide toxins from venomous
animals [76], ω-ACTX-Hv1a [18] and J-ACTX-Hv1c [39]
have been renamed ω-HXTX-Hv1a and κ-HXTX-Hv1a,
respectively, and the various paralogs and orthologs un-
covered in this study have been named accordingly.
Briefly, the Greek letter denotes the molecular target of
the peptide, followed by the generic name indicating the
family from which the toxin is derived; in this case the ab-
breviation is HXTX for hexatoxin. After the generic family
name, a two-letter abbreviation is used to denote the
genus and species, indicated by upper and lowercase let-
ters respectively (i.e., Hv for H. versuta, Hi for H. infensa,
etc.). The name of the species is immediately followed by
a numeral that helps to distinguish different toxins with
similar pharmacology and this number is followed by let-
ter that denotes the paralog number (this is based on the
number of different encoded mature toxin sequences).
Molecular evolution analyses
A total of 73 nucleotide and 90 peptide sequences were
aligned using the default settings in Geneious Pro, ver-
sion 3.8.5 [72] then manually adjusted for optimal align-
ment prior to the following molecular evolution analyses
(see Additional file 1: Figure S1 and S2).
Test for recombination
To overcome the effects of recombination on the phylo-
genetic and evolutionary interpretations [77], we employed
Single Breakpoint algorithms implemented in the HyPhy
package and assessed the effect of recombination on all the
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breakpoints were detected using the small sample Akaike
information criterion (AIC), the sequences were compart-
mentalized or partitioned before conducting selection ana-
lyses to allow the recombining units to have distinct
phylogenies (as described in [80,81]).
Selection analyses
We evaluated the influence of natural selection on the
toxins using maximum-likelihood models [82,83] imple-
mented in CODEML of the PAML software [84]. We
employed site-specific models that estimate positive selec-
tion statistically as an ω value significantly greater than 1.
We compared likelihood values for three pairs of models
with different assumed ω distributions as no a priori ex-
pectation exists for ω: M0 (constant ω rates across all
sites) versus M3 (allows ω to vary across sites within n
discrete categories, where n ≥ 3); M1a (a model of neutral
evolution) where all sites are assumed to be either under
negative (ω <1) or neutral selection (ω = 1) versus M2a (a
model of positive selection) which in addition to the site
classes mentioned for M1a, assumes a third category of
sites; sites with ω >1 (positive selection) and M7 (β) versus
M8 (β and ω), and models that mirror the evolutionary
constraints of M1 and M2 but assume that ω values are
drawn from a β distribution [85]. Only if the alternative
models (M3, M2a and M8: allow sites with ω >1) show a
better fit in a Likelihood Ratio Test (LRT) relative to their
null models (M0, M1a and M7: do not allow sites ω >1),
are their results considered significant. LRT is estimated
as twice the difference in maximum likelihood values
between nested models and compared with the χ2 distri-
bution with the appropriate degree of freedom—the differ-
ence in the number of parameters between the two
models. The Bayes empirical Bayes (BEB) approach [86]
was used to identify amino acids under positive selection
by calculating the posterior probabilities that a particular
amino acid belongs to a given selection class (neutral,
conserved, or highly variable). Sites with greater posterior
probability (PP ≥ 95%) of belonging to the ‘ω > 1 class’
were inferred to be positively selected.
FUBAR [55-57] implemented in HyPhy [78,79] was
employed to detect sites evolving under positive and nega-
tive selection. MEME [57], which is designed to overcome
the drawbacks of site-specific assessments, was used to
detect episodic diversifying selection. Mutations were also
assessed via a complementary protein-level approach im-
plemented in TreeSAAP [87]. An evolutionary fingerprint
analysis was carried out using the ESD algorithm imple-
mented in datamonkey [78,79,88] in order to clearly de-
pict the proportion of sites under different regimes of
selection.
Logo plots [54] showing cysteine codon bias were con-
structed using Geneious software, version 5.4.Shiva superfamily phylogenetic tree
The molecular evolutionary history of the Shiva super-
family toxins was reconstructed using Bayesian inference
as implemented in MrBayes version 3.2.1 [89], using lset
rates = invgamma with the prset aamodelpr =mixed com-
mand, which enables the program to optimize between
the nine different amino acid substitution matrices imple-
mented in MrBayes. WAG [90] was chosen as the best
substitution matrix by the program. Tree searches were
run using four Markov chains for a minimum of 10 mil-
lion generations, sampling every 100th tree. The log likeli-
hood score of each saved tree was plotted against the
number of generations to establish the point at which the
log-likelihood scores of the analyses reached their asymp-
tote. 25% of the total trees sampled were discarded as bur-
nin. The posterior probabilities for clades were established
by constructing a majority rule consensus tree for all trees
generated after completion of the burnin. The tree was
rooted using the sequence of ω-actinopoditoxin-Mb1a
(also known as ω-missulenatoxin-Mb1a) from the Eastern
mouse spider Missulena bradleyi as an outgroup; this
toxin also blocks CaV channels and it has sequence
homology to the ω-HXTXs, including conservation of
the ω-HXTX-Hv1a pharmacophore. However, although
M. bradleyi and Australian funnel-web spiders (family
Hexathelidae) both belong to the infraorder Mygalo-
morphae, M. bradleyi is a member of the Actinopodidae
family.
Structural alignment of omega and kappa hexatoxins
Atomic coordinates for ω-HXTX-Hv1a [18] and κ-HXTX-
Hv1c [42] were downloaded from the Protein DataBank
(PDB accession codes 1AXH and 1DL0, respectively). A
structural alignment of the toxins was automatically gen-
erated using DaliLite [70]. All structure figures were gen-
erated using MacPyMOL [91]. The Consurf webserver
[92] was used for mapping evolutionary selection pres-
sures on 3D homology models.
Availability of supporting data
Nucleic acid and protein sequence alignments and their
respective accession numbers can be accessed from the
supplementary material along with tables relevant to the
molecular evolution analyses.
Additional file
Additional file 1: Diversification of a single ancestral gene into a
successful toxin superfamily in highly venomous Australian
funnel-web spiders.
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